Sg3 Management, LLC Editas Medicine, Inc. Put Options Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	SELL	$14.08 - $27.63 $1.13 Million - $2.21 Million	-80,000 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$26.55 - $40.57 $2.58 Million - $3.94 Million	-97,100 Reduced 54.83%	80,000 $2.12 Million
Q3 2021 Nov 15, 2021	BUY	$39.27 - $72.94 $6.56 Million - $12.2 Million	167,100 Added 1671.0%	177,100 $7.28 Million
Q1 2020 May 12, 2020	BUY	$14.88 - $32.78 $148,800 - $327,800	10,000 New	10,000 $198,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $151M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.